First Wave BioPharma, Inc.
Pharmaceutical ManufacturingView the employees at
First Wave BioPharma, Inc.-
Daniel Dupret President, AzurRx SAS
-
Greater Montpellier Metropolitan Area
-
Top 5%
Matt Brieger Product Development Manager at First Wave BioPharma-
Chicago, Illinois, United States
-
Rising Star
Ted Stover Vice President Of Product Development at First Wave BioPharma, Inc.-
Delray Beach, Florida, United States
-
Top 10%
Nancy O'Malley Operations Assistant at First Wave BioPharma, Inc.-
Boynton Beach, Florida, United States
-
Top 1%
Martin Krusin Vice President Business Development at AzurRx BioPharma-
Brooklyn, New York, United States
-
Rising Star
Overview
First Wave BioPharma, Inc. (formerly AzurRx BioPharma) is a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. First Wave is currently advancing a therapeutic development pipeline populated with multiple clinical stage programs built around its two proprietary technologies – niclosamide, an oral small molecule with anti-viral and anti-inflammatory properties, and the biologic adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients. First Wave’s niclosamide portfolio is led by three clinical programs: FW-COV, for COVID-19 gastrointestinal infections; FW-UP, for ulcerative proctitis (UP) and ulcerative proctosigmoiditis; and FW-ICI-AC, for Grade 1 and Grade 2 Immune Checkpoint Inhibitor-associated colitis and diarrhea in advanced oncology patients. Two additional formulations of niclosamide, FW-UC (ulcerative colitis) and FW-CD (Crohn’s disease) are expected to enter the clinic in 2022 and 2023, respectively. First Wave is also advancing FW-EPI (adrulipase) for the treatment of exocrine pancreatic insufficiency (EPI) in patients with cystic fibrosis and chronic pancreatitis. The Company is headquartered in Boca Raton, Florida with clinical operations in Hayward, California. For more information visit www.firstwavebio.com.
-